Annual CFI
-$1.44 B
-$1.25 B-672.26%
December 1, 2024
Summary
- As of February 25, 2025, GMAB annual cash flow from investing activities is -$1.44 billion, with the most recent change of -$1.25 billion (-672.26%) on December 1, 2024.
- During the last 3 years, GMAB annual CFI has fallen by -$1.28 billion (-840.00%).
- GMAB annual CFI is now -887.96% below its all-time high of $182.42 million, reached on December 31, 2009.
Performance
GMAB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$34.70 M
+$32.61 M+1558.10%
December 1, 2024
Summary
- As of February 25, 2025, GMAB quarterly cash flow from investing activities is $34.70 million, with the most recent change of +$32.61 million (+1558.10%) on December 1, 2024.
- Over the past year, GMAB quarterly CFI has increased by +$32.61 million (+1558.10%).
- GMAB quarterly CFI is now -86.14% below its all-time high of $250.41 million, reached on June 30, 2021.
Performance
GMAB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$1.44 B
+$98.16 M+6.39%
December 1, 2024
Summary
- As of February 25, 2025, GMAB TTM cash flow from investing activities is -$1.44 billion, with the most recent change of +$98.16 million (+6.39%) on December 1, 2024.
- Over the past year, GMAB TTM CFI has increased by +$98.16 million (+6.39%).
- GMAB TTM CFI is now -750.57% below its all-time high of $220.94 million, reached on September 30, 2009.
Performance
GMAB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
GMAB Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -672.3% | +1558.1% | +6.4% |
| 3 y3 years | -840.0% | +1558.1% | +6.4% |
| 5 y5 years | -383.4% | +1558.1% | +6.4% |
GMAB Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -840.0% | at low | -76.5% | +102.7% | -840.0% | +6.4% |
| 5 y | 5-year | -840.0% | at low | -86.1% | +102.7% | -3319.2% | +6.4% |
| alltime | all time | -888.0% | at low | -86.1% | +102.7% | -750.6% | +6.4% |
Genmab A/S Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$1.44 B(+672.3%) | $34.70 M(+1558.1%) | -$1.44 B(-6.4%) |
| Sep 2024 | - | $2.09 M(-100.2%) | -$1.54 B(+10.5%) |
| Jun 2024 | - | -$1.26 B(+502.4%) | -$1.39 B(+252.7%) |
| Mar 2024 | - | -$209.89 M(+230.7%) | -$394.15 M(+111.8%) |
| Dec 2023 | -$186.13 M(-52.4%) | -$63.46 M(-143.0%) | -$186.13 M(+17.3%) |
| Sep 2023 | - | $147.42 M(-155.0%) | -$158.69 M(-67.2%) |
| Jun 2023 | - | -$268.22 M(>+9900.0%) | -$483.55 M(+65.2%) |
| Mar 2023 | - | -$1.87 M(-94.8%) | -$292.66 M(-25.2%) |
| Dec 2022 | -$391.40 M(+156.0%) | -$36.02 M(-79.7%) | -$391.40 M(-3.2%) |
| Sep 2022 | - | -$177.43 M(+129.4%) | -$404.45 M(-17.0%) |
| Jun 2022 | - | -$77.33 M(-23.1%) | -$487.42 M(+205.3%) |
| Mar 2022 | - | -$100.62 M(+105.0%) | -$159.67 M(+4.4%) |
| Dec 2021 | -$152.92 M(-57.5%) | -$49.07 M(-81.2%) | -$152.92 M(-26.1%) |
| Sep 2021 | - | -$260.40 M(-204.0%) | -$206.90 M(-39.3%) |
| Jun 2021 | - | $250.41 M(-366.8%) | -$340.72 M(-25.2%) |
| Mar 2021 | - | -$93.86 M(-8.9%) | -$455.41 M(+26.4%) |
| Dec 2020 | -$360.22 M(+21.1%) | -$103.06 M(-73.9%) | -$360.22 M(-16.3%) |
| Sep 2020 | - | -$394.21 M(-390.5%) | -$430.56 M(+924.2%) |
| Jun 2020 | - | $135.72 M(>+9900.0%) | -$42.04 M(-85.7%) |
| Mar 2020 | - | $1.33 M(-100.8%) | -$293.88 M(-1.2%) |
| Dec 2019 | -$297.34 M(+5.6%) | -$173.40 M(+2947.1%) | -$297.34 M(+36.2%) |
| Sep 2019 | - | -$5.69 M(-95.1%) | -$218.29 M(-20.3%) |
| Jun 2019 | - | -$116.12 M(+5349.9%) | -$273.84 M(+60.0%) |
| Mar 2019 | - | -$2.13 M(-97.7%) | -$171.14 M(-39.2%) |
| Dec 2018 | -$281.65 M(+177.0%) | -$94.35 M(+54.0%) | -$281.65 M(+57.1%) |
| Sep 2018 | - | -$61.25 M(+356.6%) | -$179.29 M(+47.8%) |
| Jun 2018 | - | -$13.42 M(-88.1%) | -$121.34 M(-23.6%) |
| Mar 2018 | - | -$112.64 M(-1505.6%) | -$158.85 M(+56.2%) |
| Dec 2017 | -$101.68 M(-32.6%) | $8.01 M(-342.9%) | -$101.68 M(-43.6%) |
| Sep 2017 | - | -$3.30 M(-93.5%) | -$180.31 M(-0.4%) |
| Jun 2017 | - | -$50.92 M(-8.2%) | -$180.98 M(+6.4%) |
| Mar 2017 | - | -$55.47 M(-21.4%) | -$170.07 M(+12.8%) |
| Dec 2016 | -$150.80 M | -$70.62 M(+1678.3%) | -$150.80 M(+83.6%) |
| Sep 2016 | - | -$3.97 M(-90.1%) | -$82.15 M(-3.1%) |
| Jun 2016 | - | -$40.01 M(+10.5%) | -$84.73 M(+46.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$36.20 M(+1739.9%) | -$58.01 M(-18.9%) |
| Dec 2015 | -$71.54 M(-60.3%) | -$1.97 M(-70.0%) | -$71.54 M(+16.7%) |
| Sep 2015 | - | -$6.56 M(-50.7%) | -$61.29 M(-34.7%) |
| Jun 2015 | - | -$13.29 M(-73.3%) | -$93.89 M(-34.3%) |
| Mar 2015 | - | -$49.73 M(-700.0%) | -$142.90 M(-20.7%) |
| Dec 2014 | -$180.26 M(-1612.1%) | $8.29 M(-121.2%) | -$180.26 M(+2.8%) |
| Sep 2014 | - | -$39.16 M(-37.1%) | -$175.34 M(+12.2%) |
| Jun 2014 | - | -$62.30 M(-28.5%) | -$156.29 M(+61.9%) |
| Mar 2014 | - | -$87.09 M(-759.5%) | -$96.54 M(-909.8%) |
| Dec 2013 | $11.92 M(-116.6%) | $13.20 M(-165.7%) | $11.92 M(-110.3%) |
| Sep 2013 | - | -$20.11 M(+688.9%) | -$116.29 M(+29.3%) |
| Jun 2013 | - | -$2.55 M(-111.9%) | -$89.92 M(+23.6%) |
| Mar 2013 | - | $21.37 M(-118.6%) | -$72.73 M(+1.2%) |
| Dec 2012 | -$71.90 M(-174.8%) | -$115.01 M(-1936.1%) | -$71.90 M(-262.7%) |
| Sep 2012 | - | $6.26 M(-57.2%) | $44.20 M(-37.4%) |
| Jun 2012 | - | $14.64 M(-34.1%) | $70.56 M(-16.0%) |
| Mar 2012 | - | $22.21 M(+1934.6%) | $84.01 M(-12.6%) |
| Dec 2011 | $96.16 M(-173.1%) | $1.09 M(-96.7%) | $96.16 M(+130.1%) |
| Sep 2011 | - | $32.62 M(+16.1%) | $41.78 M(-132.9%) |
| Jun 2011 | - | $28.09 M(-18.2%) | -$127.13 M(+25.2%) |
| Mar 2011 | - | $34.35 M(-164.5%) | -$101.51 M(-22.8%) |
| Dec 2010 | -$131.47 M(-172.1%) | -$53.28 M(-60.9%) | -$131.47 M(+12.6%) |
| Sep 2010 | - | -$136.29 M(-353.8%) | -$116.72 M(-171.8%) |
| Jun 2010 | - | $53.71 M(+1122.8%) | $162.64 M(+48.6%) |
| Mar 2010 | - | $4.39 M(-111.4%) | $109.41 M(-40.0%) |
| Dec 2009 | $182.42 M(+101.3%) | -$38.53 M(-126.9%) | $182.42 M(-17.4%) |
| Sep 2009 | - | $143.07 M(>+9900.0%) | $220.94 M(+183.7%) |
| Jun 2009 | - | $481.80 K(-99.4%) | $77.88 M(+0.6%) |
| Mar 2009 | - | $77.40 M | $77.40 M |
| Dec 2008 | $90.64 M(-120.9%) | - | - |
| Dec 2007 | -$434.53 M(+471.6%) | - | - |
| Dec 2006 | -$76.02 M(+256.8%) | - | - |
| Dec 2005 | -$21.30 M(+408.2%) | - | - |
| Dec 2004 | -$4.19 M(-107.6%) | - | - |
| Dec 2003 | $55.09 M(+81.5%) | - | - |
| Dec 2002 | $30.36 M | - | - |
FAQ
- What is Genmab A/S annual cash flow from investing activities?
- What is the all time high annual CFI for Genmab A/S?
- What is Genmab A/S annual CFI year-on-year change?
- What is Genmab A/S quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Genmab A/S?
- What is Genmab A/S quarterly CFI year-on-year change?
- What is Genmab A/S TTM cash flow from investing activities?
- What is the all time high TTM CFI for Genmab A/S?
- What is Genmab A/S TTM CFI year-on-year change?
What is Genmab A/S annual cash flow from investing activities?
The current annual CFI of GMAB is -$1.44 B
What is the all time high annual CFI for Genmab A/S?
Genmab A/S all-time high annual cash flow from investing activities is $182.42 M
What is Genmab A/S annual CFI year-on-year change?
Over the past year, GMAB annual cash flow from investing activities has changed by -$1.25 B (-672.26%)
What is Genmab A/S quarterly cash flow from investing activities?
The current quarterly CFI of GMAB is $34.70 M
What is the all time high quarterly CFI for Genmab A/S?
Genmab A/S all-time high quarterly cash flow from investing activities is $250.41 M
What is Genmab A/S quarterly CFI year-on-year change?
Over the past year, GMAB quarterly cash flow from investing activities has changed by +$32.61 M (+1558.10%)
What is Genmab A/S TTM cash flow from investing activities?
The current TTM CFI of GMAB is -$1.44 B
What is the all time high TTM CFI for Genmab A/S?
Genmab A/S all-time high TTM cash flow from investing activities is $220.94 M
What is Genmab A/S TTM CFI year-on-year change?
Over the past year, GMAB TTM cash flow from investing activities has changed by +$98.16 M (+6.39%)